Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 4
2004 5
2005 5
2006 6
2007 11
2008 7
2009 16
2010 14
2011 8
2012 20
2013 6
2014 16
2015 12
2016 10
2017 11
2018 13
2019 19
2020 17
2021 27
2022 8
2023 11
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

209 results

Results by year

Filters applied: . Clear all
Page 1
Hypoalbuminemia, but not derived neutrophil to lymphocyte ratio (dNLR), predicts overall survival in neuroendocrine tumours undergoing peptide receptor radionuclide therapy: A retrospective, cohort study of 557 patients.
Papantoniou D, Fröss-Baron K, Garske-Román U, Sundin A, Thiis-Evensen E, Grönberg M, Welin S, Tiensuu Janson E. Papantoniou D, et al. Among authors: sundin a. J Neuroendocrinol. 2024 Mar 13:e13379. doi: 10.1111/jne.13379. Online ahead of print. J Neuroendocrinol. 2024. PMID: 38477040
The Evolutionary History of Metastatic Pancreatic Neuroendocrine Tumours Reveals a Therapy Driven Route to High-Grade Transformation.
Backman S, Botling J, Nord H, Ghosal S, Stålberg P, Juhlin CC, Almlöf J, Sundin A, Zhang L, Moens L, Eriksson B, Welin S, Hellman P, Skogseid B, Pacak K, Mollazadegan K, Åkerström T, Crona J. Backman S, et al. Among authors: sundin a. medRxiv [Preprint]. 2024 Jan 10:2024.01.08.24300723. doi: 10.1101/2024.01.08.24300723. medRxiv. 2024. PMID: 38313278 Free PMC article. Preprint.
Use and perceived utility of [18 F]FDG PET/CT in neuroendocrine neoplasms: A consensus report from the European Neuroendocrine Tumor Society (ENETS) Advisory Board Meeting 2022.
Ambrosini V, Caplin M, Castaño JP, Christ E, Denecke T, Deroose CM, Dromain C, Falconi M, Grozinsky-Glasberg S, Hicks RJ, Hofland J, Kjaer A, Knigge UP, Kos-Kudla B, Koumarianou A, Krishna B, Lamarca A, Pavel M, Reed NS, Scarpa A, Srirajaskanthan R, Sundin A, Toumpanakis C, Prasad V. Ambrosini V, et al. Among authors: sundin a. J Neuroendocrinol. 2024 Jan;36(1):e13359. doi: 10.1111/jne.13359. Epub 2023 Dec 14. J Neuroendocrinol. 2024. PMID: 38097193
Changes in tumor-to-blood ratio as a prognostic marker for progression-free survival and overall survival in neuroendocrine tumor patients undergoing PRRT.
Weber M, Pettersson O, Seifert R, Schaarschmidt BM, Fendler WP, Rischpler C, Lahner H, Herrmann K, Sundin A. Weber M, et al. Among authors: sundin a. Eur J Nucl Med Mol Imaging. 2024 Feb;51(3):841-851. doi: 10.1007/s00259-023-06502-y. Epub 2023 Nov 10. Eur J Nucl Med Mol Imaging. 2024. PMID: 37947848 Free PMC article.
209 results